Metastatic Cancer Drugs Global Market Report 2024

Metastatic Cancer Drugs Global Market Report 2024

Including: 1) By Drug Class: HER2 Inhibitors; Immune Checkpoints Inhibitors; PARP Inhibitors; Kinase Inhibitors2) By Cancer: Breast Cancer; Lung Cancer; Liver Cancer; Hematological Cancer; Brain Cancer; Prostate Cancer; Pancreatic Cancer3) By Treatment: Chemotherapy; Immunotherapy; Hormonal Therapy; Surgery4) By Route Of Administration: Intravenous; Intramuscular; Oral Of Administration5) By End-Users: Hospitals; Specialty ClinicsCovering: Pfizer Inc.; Johnson and Johnson Services Inc.; F. Hoffmann-La Roche AG; Merck & Co. Inc.; AbbVie Inc.


Metastatic Cancer Drugs Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on metastatic cancer drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for metastatic cancer drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The metastatic cancer drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
  • The impact of higher inflation in many countries and the resulting spike in interest rates.
  • The continued but declining impact of covid 19 on supply chains and consumption patterns.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Drug Class: HER2 Inhibitors; Immune Checkpoints Inhibitors; PARP Inhibitors; Kinase Inhibitors; Other Drug Class

2) By Cancer: Breast Cancer; Lung Cancer; Liver Cancer; Hematological Cancer; Brain Cancer; Prostate Cancer; Pancreatic Cancer; Other Cancers

3) By Treatment: Chemotherapy; Immunotherapy; Hormonal Therapy; Surgery; Other Treatments

4) By Route Of Administration: Intravenous; Intramuscular; Oral; Other Routes Of Administration

5) By End-Users: Hospitals; Specialty Clinics; Other End-Users

Companies Mentioned: Pfizer Inc.; Johnson and Johnson Services Inc.; F. Hoffmann-La Roche AG; Merck & Co. Inc.; AbbVie Inc.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.


1. Executive Summary
2. Metastatic Cancer Drugs Market Characteristics
3. Metastatic Cancer Drugs Market Trends And Strategies
4. Metastatic Cancer Drugs Market - Macro Economic Scenario
4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market
5. Global Metastatic Cancer Drugs Market Size and Growth
5.1. Global Metastatic Cancer Drugs Market Drivers and Restraints
5.1.1. Drivers Of The Market
5.1.2. Restraints Of The Market
5.2. Global Metastatic Cancer Drugs Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Metastatic Cancer Drugs Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)
6. Metastatic Cancer Drugs Market Segmentation
6.1. Global Metastatic Cancer Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
HER2 Inhibitors
Immune Checkpoints Inhibitors
PARP Inhibitors
Kinase Inhibitors
Other Drug Class
6.2. Global Metastatic Cancer Drugs Market, Segmentation By Cancer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Breast Cancer
Lung Cancer
Liver Cancer
Hematological Cancer
Brain Cancer
Prostate Cancer
Pancreatic Cancer
Other Cancers
6.3. Global Metastatic Cancer Drugs Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Chemotherapy
Immunotherapy
Hormonal Therapy
Surgery
Other Treatments
6.4. Global Metastatic Cancer Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Intravenous
Intramuscular
Oral
Other Routes Of Administration
6.5. Global Metastatic Cancer Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Specialty Clinics
Other End-Users
7. Metastatic Cancer Drugs Market Regional And Country Analysis
7.1. Global Metastatic Cancer Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Metastatic Cancer Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Metastatic Cancer Drugs Market
8.1. Asia-Pacific Metastatic Cancer Drugs Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Metastatic Cancer Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Metastatic Cancer Drugs Market, Segmentation By Cancer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Metastatic Cancer Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Metastatic Cancer Drugs Market
9.1. China Metastatic Cancer Drugs Market Overview
9.2. China Metastatic Cancer Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Metastatic Cancer Drugs Market, Segmentation By Cancer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Metastatic Cancer Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Metastatic Cancer Drugs Market
10.1. India Metastatic Cancer Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Metastatic Cancer Drugs Market, Segmentation By Cancer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Metastatic Cancer Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Metastatic Cancer Drugs Market
11.1. Japan Metastatic Cancer Drugs Market Overview
11.2. Japan Metastatic Cancer Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Metastatic Cancer Drugs Market, Segmentation By Cancer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Metastatic Cancer Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Metastatic Cancer Drugs Market
12.1. Australia Metastatic Cancer Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Metastatic Cancer Drugs Market, Segmentation By Cancer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Metastatic Cancer Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Metastatic Cancer Drugs Market
13.1. Indonesia Metastatic Cancer Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Metastatic Cancer Drugs Market, Segmentation By Cancer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Metastatic Cancer Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Metastatic Cancer Drugs Market
14.1. South Korea Metastatic Cancer Drugs Market Overview
14.2. South Korea Metastatic Cancer Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Metastatic Cancer Drugs Market, Segmentation By Cancer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Metastatic Cancer Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Metastatic Cancer Drugs Market
15.1. Western Europe Metastatic Cancer Drugs Market Overview
15.2. Western Europe Metastatic Cancer Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Metastatic Cancer Drugs Market, Segmentation By Cancer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Metastatic Cancer Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Metastatic Cancer Drugs Market
16.1. UK Metastatic Cancer Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Metastatic Cancer Drugs Market, Segmentation By Cancer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Metastatic Cancer Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Metastatic Cancer Drugs Market
17.1. Germany Metastatic Cancer Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Metastatic Cancer Drugs Market, Segmentation By Cancer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Metastatic Cancer Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Metastatic Cancer Drugs Market
18.1. France Metastatic Cancer Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Metastatic Cancer Drugs Market, Segmentation By Cancer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Metastatic Cancer Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Metastatic Cancer Drugs Market
19.1. Italy Metastatic Cancer Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Metastatic Cancer Drugs Market, Segmentation By Cancer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Metastatic Cancer Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Metastatic Cancer Drugs Market
20.1. Spain Metastatic Cancer Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Metastatic Cancer Drugs Market, Segmentation By Cancer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Metastatic Cancer Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Metastatic Cancer Drugs Market
21.1. Eastern Europe Metastatic Cancer Drugs Market Overview
21.2. Eastern Europe Metastatic Cancer Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Metastatic Cancer Drugs Market, Segmentation By Cancer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Metastatic Cancer Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Metastatic Cancer Drugs Market
22.1. Russia Metastatic Cancer Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Metastatic Cancer Drugs Market, Segmentation By Cancer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Metastatic Cancer Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Metastatic Cancer Drugs Market
23.1. North America Metastatic Cancer Drugs Market Overview
23.2. North America Metastatic Cancer Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Metastatic Cancer Drugs Market, Segmentation By Cancer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Metastatic Cancer Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Metastatic Cancer Drugs Market
24.1. USA Metastatic Cancer Drugs Market Overview
24.2. USA Metastatic Cancer Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Metastatic Cancer Drugs Market, Segmentation By Cancer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Metastatic Cancer Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Metastatic Cancer Drugs Market
25.1. Canada Metastatic Cancer Drugs Market Overview
25.2. Canada Metastatic Cancer Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Metastatic Cancer Drugs Market, Segmentation By Cancer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Metastatic Cancer Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Metastatic Cancer Drugs Market
26.1. South America Metastatic Cancer Drugs Market Overview
26.2. South America Metastatic Cancer Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Metastatic Cancer Drugs Market, Segmentation By Cancer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Metastatic Cancer Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Metastatic Cancer Drugs Market
27.1. Brazil Metastatic Cancer Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Metastatic Cancer Drugs Market, Segmentation By Cancer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Metastatic Cancer Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Metastatic Cancer Drugs Market
28.1. Middle East Metastatic Cancer Drugs Market Overview
28.2. Middle East Metastatic Cancer Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Metastatic Cancer Drugs Market, Segmentation By Cancer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Metastatic Cancer Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Metastatic Cancer Drugs Market
29.1. Africa Metastatic Cancer Drugs Market Overview
29.2. Africa Metastatic Cancer Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Metastatic Cancer Drugs Market, Segmentation By Cancer, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Metastatic Cancer Drugs Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Metastatic Cancer Drugs Market Competitive Landscape And Company Profiles
30.1. Metastatic Cancer Drugs Market Competitive Landscape
30.2. Metastatic Cancer Drugs Market Company Profiles
30.2.1. Pfizer Inc.
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Johnson and Johnson Services Inc.
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. F. Hoffmann-La Roche AG
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Merck & Co. Inc.
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. AbbVie Inc.
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Metastatic Cancer Drugs Market Other Major And Innovative Companies
31.1. Bayer AG
31.2. AstraZeneca plc
31.3. Novartis AG
31.4. Sanofi S.A.
31.5. Bristol-Myers Squibb Company
31.6. Takeda Pharmaceutical Company Limited
31.7. Eli Lilly and Company
31.8. Gilead Sciences Inc.
31.9. Amgen Inc.
31.10. Astellas Pharma Inc.
31.11. Eisai Co. Ltd.
31.12. Sun Pharmaceutical Industries Ltd.
31.13. Incyte Corporation
31.14. Ipsen SA
31.15. Seagen Inc.
32. Global Metastatic Cancer Drugs Market Competitive Benchmarking
33. Global Metastatic Cancer Drugs Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Metastatic Cancer Drugs Market
35. Metastatic Cancer Drugs Market Future Outlook and Potential Analysis
35.1 Metastatic Cancer Drugs Market In 2028 - Countries Offering Most New Opportunities
35.2 Metastatic Cancer Drugs Market In 2028 - Segments Offering Most New Opportunities
35.3 Metastatic Cancer Drugs Market In 2028 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings